Minerva Neurosciences reported $7.99M in Operating Expenses for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Acadia Pharmaceuticals ACAD:US $ 228.48M 53.07M
Adma Biologics ADMA:US $ 50.59M 11.01M
ALKERMES ALKS:US 305.13M 16.95M
AstraZeneca AZN:LN 10.51B 1.79B
Biocryst Pharmaceuticals BCRX:US $ 99.88M 56.38M
Bristol Myers Squibb BMY:US $ 9.1B 247M
Dynavax Technologies DVAX:US $ 83.23M 31.12M
Eli Lilly And LLY:US $ 5405.7M 677M
Esperion Therapeutics ESPR:US $ 61.82M 9.2M
GlaxoSmithKline GSK:LN 6.98B 1.65B
Halozyme Therapeutics HALO:US $ 41.61M 3.86M
IONIS PHARMACEUT IONS:US $ 199.42M 19.98M
Johnson & Johnson JNJ:US $ 17.56B 2.4B
Marinus Pharmaceuticals MRNS:US $ 30.9M 2.26M
Merk MRK:US $ 10332M 386M
Minerva Neurosciences NERV:US $ 7.99M 13.39M
Neurocrine Biosciences NBIX:US $ 307.5M 40.8M
Novartis NOVN:VX 9.96B 998M
Novavax NVAX:US $ 494.68M 552.49M
Pfizer PFE:US $ 15788M 3271M
Takeda 4502:JP 874.91B 90.1B
Vanda Pharmaceuticals VNDA:US $ 67.86M 8.48M